Sex steroids have a significant effect on skeletal biology in men, with reduced levels being associated with lower skeletal bone mass and cortical thickness. The purpose of this study was to determine if sex steroids are associated with periodontitis and tooth loss in a cohort of 1210 older dentate men followed for 3 years. Periodontal measures included attachment loss, pocket depth, gingival bleeding, and number of teeth. Baseline serum testosterone and estradiol were measured by radioimmunoassay. Severe periodontitis was common at baseline (38%), and progression occurred in 32% of the cohort. Incident tooth loss occurred in 22% of the cohort. Testosterone, estradiol, and sex hormone binding globulin (SHBG) concentrations were not related to baseline periodontal status or number of teeth. Moreover, there was no relationship between sex steroid levels and periodontitis progression or incident tooth loss. Although periodontitis, progression of periodontitis, and tooth loss are common in older men, they were not associated with sex steroids.
Get full access to this article
View all access options for this article.
References
1.
Blank JB, Cawthon PM, Carrion-Petersen ML, Harper L, Johnson JP, Mitson E, et al. -2005-. Overview of recruitment for the osteoporotic fractures in men study -MrOS-. Contemp Clin Trials26:557–568.
2.
Daltaban O, Saygun I, Bolu E -2006-. Periodontal status in men with hypergonadotropic hypogonadism: effects of testosterone deficiency. J Periodontol77:1179–1183.
3.
Ferrini R, Barrett-Connor E -1998-. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol147:750–754.
4.
Fink HA, Ewing SK, Ensrud KE, Barrett-Connor E, Taylor BC, Cauley JA, et al. -2006-. Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab91:3908–3915.
5.
Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR, Baltimore Longitudinal Study of Aging -2001-. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab86:724–731.
6.
Jeffcoat M -2005-. The association between osteoporosis and oral bone loss. J Periodontol76-11 Suppl-:2125S–2132S.
7.
Khosla S, Riggs BL -2005-. Pathophysiology of age-related bone loss and osteoporosis. Endocrinol Metab Clin North Am34:1015–1030.
8.
Khosla S, Melton LJ 3rd, Atkinson EJ, O’Fallon WM -2001-. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab86:3555–3561.
9.
Khosla S, Melton LJ 3rd, Riggs BL -2002-. Estrogen and the male skeleton. J Clin Endocrinol Metab87:1443–1450.
10.
Khosla S, Melton LJ 3rd, Achenbach SJ, Oberg AL, Riggs BL -2006-. Hormonal and biochemical determinants of trabecular microstructure at the ultradistal radius in women and men. J Clin Endocrinol Metab91:885–891.
11.
Krall EA -2001-. The periodontal-systemic connection: implications for treatment of patients with osteoporosis and periodontal disease. Ann Periodontol6:209–213.
12.
Lerner UH -2006-. Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res85:596–607.
13.
Matsumoto AM -2002-. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci57:M76–M99.
14.
Mealey BL, Moritz AJ -2003-. Hormonal influences: effects of diabetes mellitus and endogenous female sex steroid hormones on the periodontium. Periodontol 200032:59–81.
15.
Mellström D, Johnell O, Ljunggren O, Eriksson AL, Lorentzon M, Mallmin H, et al. -2006-. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res21:529–535.
16.
Mellström D, Vandenput L, Mallmin H, Holmberg AH, Lorentzon M, Odén A, et al. -2008-. Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J Bone Miner Res23: 1552–1560.
17.
Norderyd OM, Grossi SG, Machtei EE, Zambon JJ, Hausmann E, Dunford RG, et al. -1993-. Periodontal status of women taking postmenopausal estrogen supplementation. J Periodontol64:957–962.
18.
Orwoll E, Klein R -2001-. Osteoporosis in men: epidemiology, pathophysiology, and clinical characterization. In: Osteoporosis. 2nd ed. Marcus R, Feldman D, Kelsey J, editors. San Diego: Academic Press, pp. 103–149.
19.
Orwoll E, Blank JB, Barrett-Connor E, Cauley J, Cummings S, Ensrud K, et al. -2005-. Design and baseline characteristics of the osteoporotic fractures in men -MrOS- study—a large observational study of the determinants of fracture in older men. Contemp Clin Trials26: 569–585.
20.
Orwoll E, Lambert LC, Marshall LM, Phipps K, Blank JB, Barrett-Connor E, et al. -2006-. Testosterone and estradiol among older men. J Clin Endocrinol Metab91:1336–1344.
21.
Phipps KR, Chan BK, Madden TE, Geurs NC, Reddy MS, Lewis CE, et al. -2007-. Longitudinal study of bone density and periodontal disease in men. J Dent Res86:1110–1114.
22.
Reinhardt RA, Payne JB, Maze CA, Patil KD, Gallagher SJ, Mattson JS -1999-. Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women. J Periodontol70:823–828.
23.
Shahinian VB, Kuo YF, Freeman JL, Goodwin JS -2005-. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med352: 154–164.
24.
Soory M, Tilakaratne A -2003a-. Modulation of androgen metabolism by phenytoin, oestradiol and tamoxifen in human gingival fibroblasts. J Clin Periodontol30:556–561.
25.
Soory M, Tilakaratne A -2003b-. Androgen metabolic response to indo-methacin and the alkaline phosphatase inhibitor levamisole in fibroblasts. J Clin Periodontol30:1069–1074.
26.
Taguchi A, Sanada M, Suei Y, Ohtsuka M, Nakamoto T, Lee K, et al. -2004-. Effect of estrogen use on tooth retention, oral bone height, and oral bone porosity in Japanese postmenopausal women. Menopause11: 556–562.
27.
Taubman MA, Valverde P, Han X, Kawai T -2005-. Immune response: the key to bone resorption in periodontal disease. J Periodontol76-11 Suppl-: 2033S–2041S.
28.
Tonetti MS, Claffey N, European Workshop in Periodontology Group C -2005-. Advances in the progression of periodontitis and proposal of definitions of a periodontitis case and disease progression for use in risk factor research. Group C consensus report of the 5th European Workshop in Periodontology. J Clin Periodontol32-Suppl 6-:210–213.
29.
Travison T, Araujo A, Kupelian V, O’Donnell A, McKinlay J -2007-. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab92:549–555.
30.
Vanderscheuren D, Boonen S, Bouillon R -1998-. Action of androgens versus estrogens in male skeletal homeostasis. Bone23:391–394.
31.
Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C -2004-. Androgens and bone. Endocr Rev25:389–425.
32.
Wactawski-Wende J, Hausmann E, Hovey K, Trevisan M, Grossi S, Genco RJ -2005-. The association between osteoporosis and alveolar crestal height in postmenopausal women. J Periodontol76-Suppl-: 2116–2124.
33.
Wiren KM, Orwoll ES -1999-. Androgens and bone: basic aspects. In: Osteoporosis in men: the effects of gender on skeletal health. Orwoll ES, editor. San Diego: Academic Press, pp. 211–245.
